The Little Known Benefits of the Pill

Nearly all U.S. women will use hormonal contraception sometime during their reproductive years yet many women are unaware of the non-contraceptive benefits of using this type of birth control. In general, combination hormonal contraceptives consist of a progestin (for its contraceptive effects) and a synthetic estrogen (to stabilize the endometrium and reduce unwanted spotting).

The following is a list of the most common non-contraceptive benefits of birth control. Please keep in mind that each woman may react differently to specific birth control methods, so this information is meant to be a general overview. Also, it is important to note that the main reason to use hormonal contraception is for birth control (to prevent an unintended pregnancy) — potential non-contraceptive benefits of birth control can be considered when determining ​which hormonal method may be best suited for you.



A young woman holding her birth control pills

PhotoAlto / Ale Ventura / PhotoAlto Agency RF Collections / Getty Images

Dysmenorrhea is pain resulting from intense uterine contractions during menstruation triggered by the release of prostaglandin. The pain is severe enough to limit a woman’s daily activities during that time. Dysmenorrhea is the most commonly reported menstrual disorder, affecting up to 90 percent of young women. Combination birth control pills, the NuvaRing, Implanon, Mirena IUD, and the Ortho Evra Patch have all shown some ability to diminish dysmenorrheal pain.



Premenstrual syndrome (PMS) refers to a wide range of physical or emotional symptoms that typically occur about five to 11 days before a woman starts her monthly menstrual cycle. The symptoms usually stop when menstruation begins, or shortly thereafter and is estimated to affect up to 90 percent of women, to some degree, during their childbearing years.

Premenstrual dysphoric disorder (PMDD), a severe form of PMS, is a condition that adversely affects the psychological well-being and social interactions of up to 6 percent of women of reproductive age. PMDD is marked by severe depression symptoms, self-deprecating thoughts, irritability, fatigue, and tension before menstruation. Hormone changes that occur during a woman's menstrual cycle appear to play a role in the occurrence of PMDD. Hormonal birth control methods, including extended cycle pills, have been shown to offer some relief.


Acne and Hirsutism

Acne, most commonly occurring on the face or shoulders, is a skin condition that causes whiteheads, blackheads, and inflamed red lesions (papules, pustules, and cysts) to form.

Hirsutism is excessive male-pattern hair growth in certain areas of a woman's face and bodies such as the mustache and beard area.

Androgens, the dominant sex hormones in men, can be responsible for these conditions. Women normally have low levels of androgens, but abnormally high levels of androgens can lead to excess hair growth or acne. Given that hormonal contraception can reduce the levels of free androgen in your system, certain combination OCs can be very effective in treating these conditions.


Menstrual Migraines

Sixty percent of women with migraines link their attacks to menstruation. Documented menstrual migraine occurs in 7-12 percent of women. Extended cycle pills (like Seasonique or Lybrel) and continuous hormonal contraception (including Depo Provera) can decrease hormonal fluctuations thought to trigger certain migraine attacks and bring some relief to certain migraine sufferers.


Irregular Menstrual Cycles

Many women suffer from irregularities with their menstrual cycles. Some women become anxious over not knowing when their period will start. Menstrual cycles can become unpredictable due to infrequent, irregular or no ovulation patterns. Combination hormonal contraceptives can provide the benefit of helping you regulate your monthly cycle or skip periods altogether.



Endometriosis is a condition in which the tissue that normally lines the inside of the uterus (the endometrium) grows in other areas of the body. It causes pain, irregular bleeding, and possible infertility. Endometriosis is a common problem and probably begins about the time that regular menstruation begins. Depo SubQ Provera 104 and Orilissa injections (or nasal spray) have been FDA-approved to help treat the pain associated with endometriosis. Other hormonal contraceptives may be helpful as well.



Menorrhagia is excessive menstrual bleeding and can lead to iron deficiency anemia if left untreated. It has been estimated to occur in about 10 percent of women of reproductive age, although as many as 30 percent of women will seek treatment for this condition. Contraceptives that reduce overall bleeding episodes may be especially helpful in the management of menorrhagia. These birth control methods can be a reversible treatment (with less serious side effects) for menorrhagia as the alternative treatment is endometrial ablation (a surgical procedure) that leads to sterilization.


Endometrial Cancer

Endometrial cancer is cancer that starts in the endometrium, the lining of the uterus. Most cases of endometrial cancer occur between the ages of 60 and 70 years, but rarely some cases can occur before age 45. According to the American Cancer Society, uterine cancer is the most common type of gynecologic cancer, and endometrial cancer accounts for about 90 percent of all uterine cancers. In the United States, approximately 65,950 new cases of uterine cancer are diagnosed and about 12,550 women die from this disease each year. Combination birth control pills, Mirena and Depo Provera have been clinically shown to offer protective effects against endometrial cancer.


Ovarian Cancer

Ovarian cancer is the fifth most common cancer among women. It causes more deaths than any other type of female reproductive cancer. It is estimated that approximately 19,880 new cases of ovarian cancer will be diagnosed each year, with 12,810 women dying from this disease. Reanalysis of worldwide data on combined OCs and ovarian cancer has demonstrated that ever use of combined birth control pills decreases the risk of ovarian cancer. Plus, the longer the duration of combined OC use, the greater the risk reduction.


Colorectal Cancer

Colon, or colorectal, cancer is cancer that starts in the large intestine (colon) or the rectum (end of the colon). According to the American Cancer Society, colorectal cancer is one of the leading causes of cancer-related deaths in the United States and is the fourth most common cancer in men and women. Research shows that using oral contraception ("the pill") can reduce your risk of developing colorectal cancer.


Bone Mineral Density

Bone mineral density (BMD) is a measure of bone density, reflecting the strength of bones as represented by calcium content. Bone density is the amount of bone tissue in a certain volume of bone. BMD can be an indirect indicator of osteoporosis and fracture risk. Whereas it appears that combination birth control pills may be associated with an increased bone density among women in the later reproductive years, research on other hormonal methods is limited. The use of Depo Provera and Implanon may actually decrease BMD. In fact, Depo Provera contains an FDA black box warning that Depo Provera use may lead to significant bone mineral density loss.

24 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. Daniels K, Mosher WD, Jones J. Contraceptive methods women have ever used: United States, 1982–2010. CDC National Health Statistics Reports. 2013;62.

  2. Britton LE, Alspaugh A, Greene MZ, McLemore MR. An evidence-based update on contraceptionAm Journal Nurs. 2020;120(2):22-33. doi:10.1097/01.NAJ.0000654304.29632.a7

  3. Ju H, Jones M, Mishra G. The prevalence and risk factors of dysmenorrheaEpidemiol Rev. 2014;36:104-13. doi:10.1093/epirev/mxt009

  4. The American College of Obstetricians and Gynecologists. Combined hormonal birth control: pill, patch, and ring.

  5. Matsumoto T, Asakura H, Hayashi T. Biopsychosocial aspects of premenstrual syndrome and premenstrual dysphoric disorderGynecological Endocrinology. 2013;29(1):67-73. doi:10.3109/09513590.2012.705383

  6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed. American Psychiatric Publishing, 2013. doi:10.1176/appi.books.9780890425596

  7. Rapkin AJ, Lewis EI. Treatment of premenstrual dysphoric disorderWomens Health (Lond Engl). 2013;9(6):537-556. doi:10.2217/WHE.13.62

  8. Agrawal NK. Management of hirsutismIndian J Endocrinol Metab. 2013;17(Suppl 1):S77-82. doi:10.4103/2230-8210.119511

  9. Pavlović JM, Stewart WF, Bruce CA, et al. Burden of migraine related to menses: Results from the AMPP studyJ Headache Pain. 2015;16(1):24. doi:10.1186/s10194-015-0503-y

  10. Maasumi K, Tepper SJ, Kriegler JS. Menstrual migraine and treatment options: ReviewHeadache. 2017;57(2):194-208. doi:10.1111/head.12978

  11. Burch R. Epidemiology and treatment of menstrual migraine and migraine during pregnancy and lactation: A narrative reviewHeadache: The Journal of Head and Face Pain. 2020;60(1):200-216. doi:10.1111/head.13665

  12. Calhoun AH, Batur P. Combined hormonal contraceptives and migraine: An update on the evidenceCCJM. 2017;84(8):631-638. doi:10.3949/ccjm.84a.16033

  13. World Health Organization. Endometriosis.

  14. FDA News. FDA approves new indication for Pfizer's Depo-SubQ Provera 104.

  15. U.S. Food and Drug Administration. Drug trials snapshots: ORILISSA.

  16. Matteson KA, Raker CA, Clark MA, Frick KD. Abnormal uterine bleeding, health status, and usual source of medical care: Analyses using the medical expenditures panel surveyJournal of Women’s Health. 2013;22(11):959-965. doi:10.1089%2Fjwh.2013.4288

  17. American Cancer Society. Key statistics for endometrial cancer.

  18. American Cancer Society. Cancer facts and figures 2022.

  19. American Cancer Society. Key statistics for ovarian cancer.

  20. National Cancer Institute. Cancer stat facts: Ovarian cancer.

  21. Schindler AE. Non-contraceptive benefits of oral hormonal contraceptivesInt J Endocrinol Metab. 2012;11(1). doi:10.5812%2Fijem.4158

  22. American Cancer Society. Key statistics for colorectal cancer.

  23. Huber JC, Bentz EK, Ott J, Tempfer CB. Non-contraceptive benefits of oral contraceptivesExpert Opinion on Pharmacotherapy. 2008;9(13):2317-2325. doi:10.1517/14656566.9.13.2317

  24. Lopez LM, Grimes DA, Schulz KF, Curtis KM, Chen M. Hormonal contraceptives and bone health in women. Cochrane.

Additional Reading

By Dawn Stacey, PhD, LMHC
Dawn Stacey, PhD, LMHC, is a published author, college professor, and mental health consultant with over 15 years of counseling experience.